WAYSTAR HOLDING CORP (WAY)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for WAY
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| WAY | Chief Product and AI Officer | 56 | ["CEO and co-founder of Iodine Software","co-founder and Vice President of Products at Crimson","multiple patents related to healthcare technology","Board of Directors of American Mission Hospital in Bahrain"] | [] | 2026 |
Biography sourced from the proxy statement filing.
Mr. Chan, 56, has served as Chief Product and AI Officer at Waystar since October 2025, following Waystar s acquisition of Iodine Software. He was previously Iodine s CEO, and co-founder from 2010 to 2025. Prior to Iodine, Mr. Chan was co-founder and Vice President of Products at Crimson from 2004 to 2008, a company focused on improving healthcare provider quality and profitability. Crimson was acquired by The Advisory Board Company (now Optum Insights) in 2008, and Mr. Chan continued serving in product leadership roles. Mr. Chan was also the co-founder and Vice President of Marketing at WhisperWire, which was acquired by Concentrix, a telecommunications software vendor. Mr. Chan has a bachelor s degree in Computer Science from Cornell University and an MBA with honors from Harvard Business School. He holds multiple patents related to healthcare technology. Mr. Chan is on the Board of Directors of American Mission Hospital in Bahrain, and also serves as an advisor to Revival Health, a healthcare technology startup.